跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge
Approved
STANDARD
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
8e1356cdc3b06fae
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8e1356cdc3b06fae
Product Name
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge
Artg Id
169633
Artg Name
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2011-04-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0d1b6b2751869765873eb2b7cd35e0c1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1c6fb81570b704726c7daa625010ea96.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
8e1356cdc3b06fae
Type
Standard
Back to TGA Approvals
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge - TGA Drug Approval Details